A new study has revealed that fatty fold of tissue within the abdomen that is a rich source of stem cells can help in fighting kidney failure.
The study found that stem cells from within a chronic kidney disease patient's own abdomen could be used to preserve and possibly improve kidney function, New Scientist reported.
However, such a treatment would require injecting cells frequently over a period of many months and years, as stem cells do not survive in the body for more than a few days after injection.
Ashok Singh, from John H Stroger Jr Hospital of Cook County, and his colleagues tested on rats with kidney disease by connecting the omentum, a fatty fold of tissue to the kidney.
The research has revealed that stem cells indeed possess the power to slow or even reverse chronic kidney disease, provided the cells are allowed to remain in the diseased kidney for a prolonged period of time.
The study was published in Journal of the American Society of Nephrology.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
